Today we provided an update on Q3 financial results. CEO Michael Severino, MD, on the quarter and what’s ahead. Read more: bit.ly/4kzOjjt
Sarepta Therapeutics
This account is verified because it's an official organization on X. Learn more@Sarepta
Commercial-stage biopharma company focused on the discovery & development of precision genetic medicine to treat rare neuromuscular diseases. bit.ly/3XgXshH
62 Following 6.6K Followers 1.1K Posts
Latest posts 5
Today we released our financial results for Q3 2026 and provided an update on clinical development programs. Read the release: bit.ly/4kzOjjt
Attending #WMS2026? We have six poster presentations at the 31st Annual International Congress of the World Muscle Society, taking place in Hiroshima, Japan, from Sept 29 – Oct 3. Learn more at wms2026.com.
We look forward to joining researchers, clinicians, advocates and industry partners from around the world at the World Muscle Society Annual Congress #WMS2026. As a Principle Partner, we're excited to be part of the conversation. Come visit us at booth #7.
As we mark the 10-year anniversary of the U.S. FDA approval of the first therapy specifically for Duchenne, we also celebrate the community that has helped drive progress. Thank you to the patients, families, advocates and researchers whose contributions have helped shape more than a decade of progress.
For U.S. residents
For U.S. residents
1:20